Background Previous studies have demonstrated a substantial economic impact of irritable
bowel syndrome (IBS). Aims To provide contemporaneous estimates of direct healthcare …

Background Irritable bowel syndrome (IBS) is highly prevalent worldwide but mechanisms
for healthcare seeking behaviours in this patient group are poorly understood. Objective To …

OBJECTIVE: We performed an evaluation of patient symptoms, health care use, and costs to
define the burden of illness of irritable bowel syndrome (IBS) and the relation to the severity …

Background & Aims Irritable bowel syndrome (IBS) is associated with substantial costs to
society. Extensive data on direct costs (health care consumption) and indirect costs (health …

Objective. Irritable bowel syndrome (IBS) is associated with increased use of health care
services. This study aims to estimate the costs of IBS in relation to differing diagnostic criteria …

Background & Aims The estimated prevalence of irritable bowel syndrome (IBS) using Rome
IV criteria in the United States (US) ranges from 4.7% to 5.3%, although these estimates …

Background & Aims Irritable bowel syndrome (IBS) is a chronic functional bowel disorder
diagnosed using the Rome criteria, which have evolved since their original description 30 …

Aim To assess the proportion of physician-diagnosed irritable bowel syndrome (IBS)
patients who conform to Rome II criteria, and evaluate the impact of IBS on quality of life …

AIM To estimate annual direct and indirect costs for patients diagnosed with irritable bowel
syndrome (IBS) and subtypes. METHODS Patients completed a standardized questionnaire …

OBJECTIVE: To provide an overall estimate of the direct, indirect and total costs of irritable
bowel syndrome (IBS) for the adult population of the European countries with universal …